UCB
€205.10Change from previous close: −0.82%Absolute change: −€1.70
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €38.38B
- Enterprise value
- €41.2B
- P/E (trailing 12 months)
- 17.8
- Forward P/E
- 14.6
- PEG
- 1.09
- Price/book
- 3.29
- Price/sales
- 4.50
- EV/EBITDA
- 12.3
- EV/revenue
- 4.83
Profitability and growth
- Gross margin
- 76.2%
- Operating margin
- 33.3%
- Net margin
- 25.7%
- ROE
- 20.6%
- ROA
- 9.0%
- Revenue growth (year over year)
- 22.5%
- Earnings growth (year over year)
- 134.8%
Financial health
- Total cash
- €766M
- Total debt
- €3.59B
- Debt/equity
- 0.31
- Current ratio
- 1.20
- Quick ratio
- 0.72
Dividends
- Annual dividend per share
- €1.45
- Dividend yield
- 0.7%
- Payout ratio
- 12.8%
- Ex-dividend date
- May 4, 2026
Analysts and estimates
- Average price target
- €285.00
- Median price target
- €295.00
- High price target
- €340.00
- Low price target
- €208.00
- Number of analysts
- 19
- Consensus
- Buy
- Forward EPS
- €13.79
- EPS estimate, current year
- €11.69
Shares and trading
- Beta
- 0.18
- Average volume
- 232.76K
- Shares outstanding
- 190.66M
- Float
- 120.16M
- Institutional ownership
- 39.6%
- Insider ownership
- 36.3%